SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:kth-350701"
 

Search: onr:"swepub:oai:DiVA.org:kth-350701" > Mammalian cell disp...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Thalén, NiklasKTH,Proteinteknologi (author)

Mammalian cell display with automated oligo design and library assembly allows for rapid residue level conformational epitope mapping

  • Article/chapterEnglish2024

Publisher, publication year, extent ...

  • Springer Nature,2024
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:kth-350701
  • https://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-350701URI
  • https://doi.org/10.1038/s42003-024-06508-8DOI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • QC 20240719
  • Precise epitope determination of therapeutic antibodies is of great value as it allows for further comprehension of mechanism of action, therapeutic responsiveness prediction, avoidance of unwanted cross reactivity, and vaccine design. The golden standard for discontinuous epitope determination is the laborious X-ray crystallography method. Here, we present a combinatorial method for rapid mapping of discontinuous epitopes by mammalian antigen display, eliminating the need for protein expression and purification. The method is facilitated by automated workflows and tailored software for antigen analysis and oligonucleotide design. These oligos are used in automated mutagenesis to generate an antigen receptor library displayed on mammalian cells for direct binding analysis by flow cytometry. Through automated analysis of 33930 primers an optimized single condition cloning reaction was defined allowing for mutation of all surface-exposed residues of the receptor binding domain of SARS-CoV-2. All variants were functionally expressed, and two reference binders validated the method. Furthermore, epitopes of three novel therapeutic antibodies were successfully determined followed by evaluation of binding also towards SARS-CoV-2 Omicron BA.2. We find the method to be highly relevant for rapid construction of antigen libraries and determination of antibody epitopes, especially for the development of therapeutic interventions against novel pathogens.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Karlander, MaximilianKTH,Proteinteknologi(Swepub:kth)u17zju4z (author)
  • Lundqvist, MagnusKTH,Proteinteknologi(Swepub:kth)u1hfekeg (author)
  • Persson, HelenaKTH,Science for Life Laboratory, SciLifeLab,Läkemedelsutveckling(Swepub:kth)u1l700sh (author)
  • Hofström, CamillaKTH,Science for Life Laboratory, SciLifeLab,Läkemedelsutveckling(Swepub:kth)u12237py (author)
  • Turunen, S. PauliinaKTH,Läkemedelsutveckling,Science for Life Laboratory, SciLifeLab(Swepub:kth)u1cqvltr (author)
  • Godzwon, MagdalenaDepartment of Immunotechnology, Lund University, Lund, Sweden (author)
  • Volk, Anna-LuisaKTH,Proteinteknologi(Swepub:kth)u1j049o2 (author)
  • Malm, Magdalena,1983-KTH,Proteinteknologi(Swepub:kth)u1cmkpee (author)
  • Ohlin, MatsDepartment of Immunotechnology, Lund University, Lund, Sweden (author)
  • Rockberg, JohanKTH,Proteinteknologi(Swepub:kth)u130jo0a (author)
  • KTHProteinteknologi (creator_code:org_t)

Related titles

  • In:Communications Biology: Springer Nature7:12399-3642

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view